SC Launch Company Klaren Technologies Inc. Selected to Present at Cavendish Global Health Impact Forum
May 5, 2014
GREENVILLE, SC – May 5, 2014 – Klaren Technologies Inc. (“Klaren”) will present at the Cavendish Global Health Impact Forum taking place May 5-7, 2014 in New York, NY. Klaren is developing a game-changing medical sterilizer that will enable effective sterilization of heat or chemical sensitive materials, whether metal, electronic or plastic, in a few minutes or less.
Cavendish Innovation Partners are provided opportunities to interact with and present to the Cavendish Global Family representatives and members, in both a formal and informal way, such as through the Cavendish Global Health Impact Forum. The purpose of the Forum is to help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within health and the life sciences. To accomplish this mission the Forum showcases presentations and panel discussions by leading scientists, accomplished healthcare delivery professionals, health-policy experts and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis and treatment. Michael Moffat, Cavendish co-founder and President explains, “With the help of our expert advisors, we conduct a global search of research institutions and private-sector companies in order to identify organizations that meet the required standard of excellence. The quality and originality of Klaren’s research and scientific insights in sterilization systems which can help both the western as well as the developing world health systems positions them to make a major contribution to reduction in hospital acquired infections which lead to hundreds of thousands preventable deaths a year.”
“We are honored at being selected to present at this unique event, and it is further recognition of the potential of our innovative approach to prevent many infections that can be acquired in a healthcare setting, a problem that afflicts populations around the world today,” said David E. Huizenga, Ph.D., CEO of Klaren. “We welcome the chance to interact with many of the world’s leading scientific minds, thought-leaders and generous philanthropic individuals and families who are all dedicated to the common cause of improving the health and lives of people around the world.”
Cavendish Global consists of over 150 leading family offices and foundations from around the world with combined assets of over $190 billion who share a passion for pro-social endeavors within health and the life sciences. The Cavendish Global Health Impact Forum provides family offices with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the information and educational resources required by foundations actively seeking to accelerate technological innovation and health access through sustainable philanthropy, grant-making and impact investing. The Forum is also an opportunity for family offices to champion and share information on projects and organizations, which they are passionate about with other family offices from around the world. Cavendish Global together with the Global Partnerships Forum and the New York Academy of Sciences organizes the Forum annually in New York.
About Klaren Technologies Inc.
Klaren Technologies Inc. is a life science company dedicated to reducing the number of hospital acquired infections occurring in both western level, as well as developing world, health care facilities. Millions of infections are transmitted every year from health facility to patient via less-than-sterile medical instruments. Many of these infections, such as HIV and HCV, account for hundreds of thousands of deaths worldwide. The Klaren technology allows for a low energy solution that can be run from a car battery, without the use of chemicals or high heat, each of which can damage sensitive instruments and devices. The Klaren technology is designed to be able to sterilize a used syringe in a rural health center, as well as the latest medical devices, such as dental digital x-ray devices. Both the syringe and the digital x-ray device represent current devices that cannot be sterilized in real time in a health care facility. Klaren Technologies Inc. is a subsidiary of Tao Life Sciences Inc., a technology development and investment company; and is a Client Company of the SC Launch Program, the award winning seed capital program of SCRA Technology Ventures of South Carolina.
Further information is available on the Company’s website, www.klarentech.com.
About Cavendish Global
Cavendish Global provides family offices and their foundations with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the innovative resources required to help develop and implement their individual pro-social impact investment, grant making and philanthropy programs within health and the life sciences. Cavendish Global provides family offices with a number of innovative resources, which includes Cavendish Impact Forums. A unique gathering of leading family offices, Cavendish Impact Forums take place three times each year; in the United States (taking place in New York at the United Nations Headquarters May 5th to 7th 2014), Europe (London, November 2014, in association with SV Life Sciences, hosted by Oxford University ) and a third event held at a Cavendish Host Partner City which moves to a different global location each year (Dubai, UAE January 2015).
For more information: http://cavendishglobal.com
